Adverse Event Reporting & Case Management Flashcards
7 cards from real PVC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Adverse Event Reporting & Case Management flashcards as text
A company receives an adverse event report from a published scientific journal article. What is the 'clock start' date for reporting purposes?
Answer: The date any company employee first becomes aware of the report containing minimum case criteria
Day 0 (clock start) is the date any employee of the company — in any department — first receives information that meets minimum case criteria, regardless of publication date.
Under ICH E2B(R3), in which format must ICSRs be electronically transmitted to regulatory authorities?
Answer: ICH E2B(R3) XML using the ICSR schema
ICH E2B(R3) requires ICSRs to be transmitted as XML files conforming to the ICH ICSR message specification, replacing the earlier E2B(R2) standard.
What is the key difference between a 'follow-up' report and an 'amendment' in ICSR case management?
Answer: A follow-up adds new information to an ongoing case; an amendment corrects errors in a previously submitted report
A follow-up report provides new or updated clinical information about an existing case, while an amendment corrects factual errors in a previously submitted ICSR.
Which coding dictionary is the international standard for classifying adverse event terms in pharmacovigilance reporting?
Answer: MedDRA (Medical Dictionary for Regulatory Activities)
MedDRA is the internationally agreed medical terminology standard mandated by ICH and regulatory agencies worldwide for coding adverse events in safety reports.
A healthcare professional reports that a patient developed severe hepatotoxicity after taking a company's drug. The reporter states 'I think the drug caused this.' How should the company classify causality?
Answer: As related, because a healthcare professional's expressed opinion constitutes a positive causality assessment
When a qualified healthcare professional provides a causal opinion connecting a product to an adverse event, this constitutes a positive causality assessment that must be accepted for reporting purposes.
In the context of aggregate safety reporting, what is the purpose of a Periodic Benefit-Risk Evaluation Report (PBRER)?
Answer: To provide a periodic comprehensive benefit-risk evaluation of a marketed product using cumulative safety data
The PBRER (replacing the PSUR) provides a cumulative assessment of a marketed product's benefit-risk profile at defined intervals, incorporating all safety data from the data lock point.
What does 'expectedness' mean in the context of an adverse event, and which document determines it?
Answer: Whether the adverse event is consistent with what is described in the reference safety information (RSI) such as the SmPC or IB
Expectedness is determined by comparing the reported adverse event to the Reference Safety Information (RSI) — the SmPC for marketed products or the Investigator's Brochure in clinical trials.